Speedier OKs In Sight For Cancer Drugs June 14, 2012 By AxoGen, Inc. A novel trial design using neoadjuvant treatment to monitor response may accelerate the way cancer drugs are approved for early-stage disease, as this exclusive InFocus report outlines.
What’s next for Capstan Medical after their first-in-human robot-assisted transcatheter heart valve replacement
